Current Medicinal Chemistry
Title:Editorial: [Hot Topic: Chromogranin A at the Crossroads of Health and Disease]
Volume: 19 Issue: 24
Author(s): T. Angelone and B. Tota
Affiliation:
Export Options
About this article
Cite this article as:
Angelone T. and Tota B., Editorial: [Hot Topic: Chromogranin A at the Crossroads of Health and Disease], Current Medicinal Chemistry 2012; 19 (24) . https://dx.doi.org/10.2174/092986712802430027
DOI https://dx.doi.org/10.2174/092986712802430027 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Current Drug Targets Impact of N-acetylcysteine and Etodolac Treatment on Systolic and Diastolic Function in a Rat Model of Myocardial Steatosis Induced by High-Fat-Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases
Current Drug Targets Propranolol Safety Profile in Children
Current Drug Safety Uric Acid and Oxidative Stress
Current Pharmaceutical Design Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Allopurinol Hypersensitivity Reactions: Desensitization Strategies and New Therapeutic Alternative Molecules
Inflammation & Allergy - Drug Targets (Discontinued) Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Recent Patents on Polymeric Scaffolds for Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) Clozapine Safety, 40 Years Later
Current Drug Safety NADPH Oxidases in the Heart
Current Cardiology Reviews Cardiac Effects of Anabolic Steroids: Hypertrophy, Ischemia and Electrical Remodelling as Potential Triggers of Sudden Death
Mini-Reviews in Medicinal Chemistry N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Current Pharmaceutical Design Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients
Reviews on Recent Clinical Trials New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews